Increased Expression of Pro-inflammatory Cytokines at the Fetal-maternal Interface in Bovine Pregnancies Produced by Cloning
Overview
Reproductive Medicine
Authors
Affiliations
Problem: A significant rate of spontaneous abortion is observed in cattle pregnancies produced by somatic cell nuclear transfer (SCNT). Major histocompatibility complex class I (MHC-I) proteins are abnormally expressed on the surface of trophoblast cells from SCNT conceptuses.
Method Of Study: MHC-I homozygous compatible (n = 9), homozygous incompatible (n = 8), and heterozygous incompatible (n = 5) pregnancies were established by SCNT. Eight control pregnancies were established by artificial insemination. Uterine and trophoblast samples were collected on day 35 ±1 of pregnancy, the expression of immune-related genes was examined by qPCR, and the expression of trophoblast microRNAs was assessed by sequencing.
Results: Compared to the control group, trophoblast from MHC-I heterozygous incompatible pregnancies expressed increased levels of CD28, CTLA4, CXCL8, IFNG, IL1A, IL2, IL10, IL12B, TBX21, and TNF, while GNLY expression was downregulated. The MHC-I homozygous incompatible treatment group expressed increased levels of IFNG, IL1A, and IL2 while the MHC-I homozygous compatible group did not differentially express any genes compared to the control group. In the endometrium, relative to the control group, MHC-I heterozygous incompatible pregnancies expressed increased levels of CD28, CTLA4, CXCL8, IFNG, IL10, IL12B, and TNF, while GATA3 expression was downregulated. The MHC-I homozygous incompatible group expressed decreased amounts of CSF2 transcripts compared with the control group but did not have abnormal expression of any other immune-related genes. MHC-I incompatible pregnancies had 40 deregulated miRNAs compared to control pregnancies and 62 deregulated microRNAs compared to MHC-I compatible pregnancies.
Conclusions: MHC-I compatibility between the dam and fetus prevented an exacerbated maternal immune response from being mounted against fetal antigens.
Farifteh F, Fazeli E, Hosseini S, Soheila Arefi S, Moini A, Taheripanah R Int J Reprod Biomed. 2023; 21(4):343-354.
PMID: 37260554 PMC: 10227356. DOI: 10.18502/ijrm.v21i4.13273.
Resurrecting biodiversity: advanced assisted reproductive technologies and biobanking.
Bolton R, Mooney A, Pettit M, Bolton A, Morgan L, Drake G Reprod Fertil. 2022; 3(3):R121-R146.
PMID: 35928671 PMC: 9346332. DOI: 10.1530/RAF-22-0005.
Rutigliano H, Thomas A, Umbaugh J, Wilhelm A, Sessions B, Kaundal R Am J Reprod Immunol. 2022; 87(3):e13520.
PMID: 34974639 PMC: 9285385. DOI: 10.1111/aji.13520.